NCT02904551

Brief Summary

This prospective controlled randomized blind clinical study investigated 44 implants displaying lack of KG in 29 subjects. Fourteen subjects received FGGs followed by oral prophylaxis. Fifteen subjects in the control group did not receive FGGs. The width of KG, gingival recession (GR), pocket depths (PD), plaque index (PI) and gingival index (GI) were assessed at baseline, 6, 12, and 18 months. Changes in crestal bone levels, from baseline, were assessed at 18 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2016

Completed
Last Updated

December 11, 2024

Status Verified

August 1, 2019

Enrollment Period

4.3 years

First QC Date

September 9, 2016

Last Update Submit

December 5, 2024

Conditions

Keywords

prospective studyfree gingival graftkeratinized gingivadental implant

Outcome Measures

Primary Outcomes (1)

  • Changes in the width of Keratinized Gingiva from baseline to 6, 12, 18 months

    6, 12, 18 months

Study Arms (2)

Experimental

EXPERIMENTAL

Free gingival grafts

Procedure: Free gingival graft

Control

ACTIVE COMPARATOR

Oral prophylaxis

Procedure: Oral prophylaxis

Interventions

After infiltration anesthesia, a recipient bed was prepared with a horizontal split-thickness incision made with a 15 stainless steel blade at the mucogingival junction (MGJ) on the facial side of the selected implants. An intermediate thickness (0.75 mm) graft was taken from the palate. The graft was sutured with 6-0 polypropylene suture at the recipient site. Co-Pak® was applied on the recipient site. Analgesics (over-the-counter Tylenol or Ibuprofen) were prescribed for 5-7 days. PeridexTM (3M, St. Paul, MN) was prescribed for 7-10 days. No antibiotics were prescribed in relation to the surgery.

Also known as: Experimental
Experimental

Oral prophylaxis is a regular dental cleaning. Titanium periodontal curette and superfloss were used on implant sites. Stainless steel periodontal curettes and a piezo scaler were used for natural teeth.

Also known as: Control
Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • less than 2 mm KG present on the facial side of implant
  • implant restoration is single unsplinted unit, and has been in function for at least 6 months with an opposing dentition.

You may not qualify if:

  • uncontrolled hypertension
  • diabetes mellitus (DM),
  • subjects with a history of a long-term (\>6 months) use of corticosteroid
  • subjects currently taking bisphosphonates, or with a history of taking bisphosphonates regardless of route of administration
  • subjects on medications that cause gingival hyperplasia
  • smokers
  • pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Advanced General Dentistry at UMB DS

Baltimore, Maryland, 21201, United States

Location

Study Officials

  • Se-Lim Oh, DMD, MS

    University of Maryland School of Dentistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 9, 2016

First Posted

September 19, 2016

Study Start

February 1, 2012

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

December 11, 2024

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

IPD will not be shared. The results will be published.

Locations